News
DBT invites feedback on Nanopharmaceuticals Guidelines
Institutions, industry, and researchers engaged in research & development in Nanobiotechnology have been reached by the Department of Biotechnology to seek comments on “Guidelines for evaluation of nanopharmaceuticals in India”.
Bharat Biotech acquires Chiron Behring Vaccines
Hyderabad-based vaccine major, Bharat Biotech will acquire 100% equity stake in Chiron Behring Vaccines in an all cash transaction, subject to a number of closing conditions which Bharat Biotech and GSK intend to complete in the coming weeks.
